Literature DB >> 8391725

Factors favoring continence, the avoidance of a diverting ileostomy and small intestinal conservation in the ileoanal pouch operation.

P M Mowschenson1, J F Critchlow, S J Rosenberg, M A Peppercorn.   

Abstract

Ileoanal pouch operation was performed upon 38 consecutive patients with ulcerative colitis (36 patients) or familial polyposis (two patients). Mucosectomy was avoided by rectal mobilization to the dentate line and eversion and stapling of the exteriorized anorectal junction with the dentate line in view. An 8 centimeter J pouch was stapled to the anorectal junction. A diverting ileostomy was not used in 34 of the 38 patients. Physicians independent of the operation evaluated patients postoperatively. Eighty-four percent of the patients did not experience any problems with incontinence or nocturnal spotting at one month postoperatively. No incontinence or nocturnal spotting was seen in any patient by one year postoperatively, with the exception of one patient with chronic pouchitis who had occasional nocturnal spotting that continues to improve. The average number of bowel movements per 24 hours was five at 12 months postoperatively, despite the small pouch. The mean distance from the dentate line to the ileoanal anastomosis was 0.9 +/- 0.5 centimeter (range of zero to 2 centimeters).

Entities:  

Mesh:

Year:  1993        PMID: 8391725

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  3 in total

1.  Ileal pouch anal anastomosis without ileal diversion.

Authors:  H J Sugerman; E L Sugerman; J G Meador; H H Newsome; J M Kellum; E J DeMaria
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

2.  Laparoscopically assisted resection of the lower rectum.

Authors:  J Tanaka; M Ito; Y Shindo; H Kotanagi; K Koyama
Journal:  Surg Endosc       Date:  1996-03       Impact factor: 4.584

Review 3.  Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited.

Authors:  Alex Kartheuser; Pierre Stangherlin; Dimitri Brandt; Christophe Remue; Christine Sempoux
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.